Projets soutenus - GRANTS - YOUNG INVESTIGATOR

Anciens projets - GRANTS - YOUNG INVESTIGATORS

Appel à projets - Call for projects

Fond’Action contre le cancer a pour mission de soutenir et de promouvoir la recherche contre le cancer appliquée aux patients.

Date de soumission pour les Grant Requests et le Young Investigator Award:
15 septembre 2024

Remise du Young Investigator Award 2024

Fond’Action contre le cancer est heureuse et fière d’annoncer que le prix du Young Investigator Award 2024 de CHF 100’000.- vient d’être attribué au Docteur Andreas Reichmuth de l’université de Zürich.

Le Dr. Reichmuth devient ainsi le 6ème lauréat du prix de Fond’Action, récompensant un jeune chercheur de moins de 40 ans.

Voir le communiqué de presse

Le Dr. Andreas Reichmuth entouré des Professeurs Daniel Schorderet (à droite), Président du Comité scientifique, et de Serge Leyvraz, Président de Fond’Action contre le cancer.

Articles scientifiques

Activité physique cancer enfant

Adherence and contamination in a 1- year physical activity program in childhood cancer survivors: A report from the SURfit study

Cancer Medicine | 5 mai 2023

Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit)

INTERNATIONAL JOURNAL of CANCER | 12 juillet 2023

High impact physical activity and bone health of lower extremities in childhood cancer survivors: A cross-sectional study of SURfit

INTERNATIONAL JOURNAL of CANCER | 13 mars 2020

Cancer de la cavité abdominale / péritoine

Nab- PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab- paclitaxel ...

BMJ Open | 23 janvier 2023

Cancer de la prostate
YIA 2020

Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens

The journal of Pathology | 2 mai 2021

Patterns of stemness‐associated markers in the development of castration‐resistant prostate cancer

The prostate | 14 avril 2020

Cancer de la prostate
YIA 2021

Minor intron splicing is critical for survival of lethal prostate cancer

Sciencedirect.ch | 15 juin 2023

Chirurgie du cancer du sein

Tailored axillary surgery – A novel concept for clinically node positive breast cancer

The Breast | 2023

Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer

JAMA Surgery | 19 juillet 2023

Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study

Breast Cancer Research and Treatment | 26 mai 2023

ASO Visual Abstract: Impact of Imaging‑Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node‑Positive Breast Cancer: Prospective Cohort Study Within TAXIS

Breast Cancer Research and Treatment | 25 mars 2023

Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS

The Breast | 2021

Génome du mélanome de l’oeil

Mieux guérir le mélanome de l'oeil

24 Heures/ ATS | Octobre 2016

Comprehensive genetic landscape of uveal melanoma by whole-genome sequencing

the American Journal of Human Genetics | Septembre 2016

UV light signature in conjunctival melanoma; not only skin should be protected from solar radiation

Journal of Human Genetics | Décembre 2015

Immunothérapie

Current strategies for vaccination in glioblastoma

journals.lww.com | Novembre 2019

Recherche tansrationnelle en onco-hématologie p140-146

Schweizer Krebs Bulletin | Juin 2019

Exploratory study of the effect of IMA950/Poly-ICLC

Journal MDPI | Avril 2019

Phase I/II trial testing

Neuro-oncology | Février 2019

Actively personalized vaccination trial for newly diagnosed glioblastoma

Nature | VOL 565 | 10 janvier 2019

Publisher Correction : Actively personalized vaccination trial for newly diagnosed glioblastoma

Nature | 19 décembre 2018

First report of clinical responses to immunotherapy

Journal on oncoimmunlogy | Août 2017

Immunotherapy of Malignant Tumors in the Brain

Frontiers in Oncology | Décembre 2016

Leucémie myéloïde

CRP Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70

A Retrospective Study | Cancers 2023, 15, 1479

Leucémies myéloïdes aiguës

Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia

CDD press | 28 mars 2024

CRP Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70

A Retrospective Study | 25 février 2023

CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells

Journal MDPI | 21 octobre 2021

Lymphome de Hodgkin

Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma

BJH | 7 août 2023

Genetic and phenotypic attributes of splenic marginal zone lymphoma

Blood, Volume 139, Number 5 | 3 February 2022

Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab

Blood advances | 23 novembre 2021

Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma

BJH | 22 juillet 2021

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

Blood, 2020, 135 (21): 1859-1869 | 21 mai 2020

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia

Haematologica Volume 105(2):448-456 | 2020

Radiothérapie

Irradiation in a flash

Radiotherapy and Oncology | Mai 2017

An ion recombination model for the advanced Markus

Medical Physics | Mars 2017

Radiation Toxicity

Science Translational Medicine | Juillet 2014

Soins oncologiques à domicile

Isabelle Crettol, Réseau de soins oncologiques de proximité en Valais central

ResOnco 7.2017 pages 66-68

Isabelle Crettol, Onc'Oral-Accompagnement téléphonique

Onkologiepflege 2.2020, pages 37-38

Présentation programme ResOnco et Onc'Oral 2023

Traitement du Mélanome

New Generation Vaccine Induces...

The Journal of Immunology | 5 Mars 2015

Sensitive Gene Expression Profiling...

The Journal of Immunology | 5 Mars 2015

MART-1 peptide vaccination plus IMP321...

Journal of Translational Medicine | 2014

Characterization of Melan-A reactive memory...

International Immunology, Vol. 20 | 23 Juin 2008

Combination of Transient Lymphodepletion...

Immunother, volume 30 | Mars 2007

Phenotypic and Functional Analysis of Human...

Stem cells and development | 2007

Decreased specific CD8+ T cell cross-reactivity...

European Journal of Immunology | 2006

Immuno-monitoring of CD8+ T cells...

JIM Journal of Immunological Methods | 27 Décembre 2005